Author

Karol Szczepanek

AstraZeneca (United Kingdom)ORCID 0000-0001-6934-8505Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Karol Szczepanek1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Christina R. RossiD· 1 shared Jack D. SanfordiD· 1 shared Kent W. HunteriD· 1 shared Larry V. Pearce· 1 shared Tinghu Qiu· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Christina R. RossORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJan 15, 2025

Investigating the genomic landscape of mouse models of breast cancer metastasis

Christina R. Ross, Karol Szczepanek, Jack D. Sanford…·Kent W. Hunter

This study examines four mouse breast cancer models to show that oncogenic drivers influence metastasis-specific copy number variations and gene expression, while genetic background also plays a significant role.

DOI 10.1101/2025.01.15.633216

mousebulk RNA-seq

𝕏 PostBluesky